phenazopyridine has been researched along with Sulfhemoglobinemia in 5 studies
Phenazopyridine: A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
phenazopyridine : A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
Sulfhemoglobinemia: A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of sulfhemoglobinemia in a patient receiving phenazopyridine for a urinary tract infection." | 7.73 | Phenazopyridine-induced sulfhemoglobinemia. ( Bharadwaj, P; Bowie, VL; Gopalachar, AS, 2005) |
| "Sulfhemoglobinemia is a rare dyshemoglobinemia that presents similarly to methemoglobinemia." | 5.62 | Case Report: Phenazopyridine-Induced Sulfhemoglobinemia in an 83-Year-Old Presenting with Dyspnea. ( Brown, W; Checinski, P; Morales, A; Walsh, R; Williams, SR, 2021) |
| "To report a case of sulfhemoglobinemia in a patient receiving phenazopyridine for a urinary tract infection." | 3.73 | Phenazopyridine-induced sulfhemoglobinemia. ( Bharadwaj, P; Bowie, VL; Gopalachar, AS, 2005) |
| "Sulfhemoglobinemia is a rare dyshemoglobinemia that presents similarly to methemoglobinemia." | 1.62 | Case Report: Phenazopyridine-Induced Sulfhemoglobinemia in an 83-Year-Old Presenting with Dyspnea. ( Brown, W; Checinski, P; Morales, A; Walsh, R; Williams, SR, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morales, A | 1 |
| Walsh, R | 1 |
| Brown, W | 1 |
| Checinski, P | 1 |
| Williams, SR | 1 |
| Kermani, TA | 1 |
| Pislaru, SV | 1 |
| Osborn, TG | 1 |
| Gopalachar, AS | 1 |
| Bowie, VL | 1 |
| Bharadwaj, P | 1 |
| Halvorsen, SM | 1 |
| Dull, WL | 1 |
| Lim, TP | 1 |
| Lower, D | 1 |
5 other studies available for phenazopyridine and Sulfhemoglobinemia
| Article | Year |
|---|---|
Case Report: Phenazopyridine-Induced Sulfhemoglobinemia in an 83-Year-Old Presenting with Dyspnea.
Topics: Aged, 80 and over; Cyanosis; Dyspnea; Female; Humans; Methemoglobinemia; Methylene Blue; Oximetry; P | 2021 |
Acrocyanosis from phenazopyridine-induced sulfhemoglobinemia mistaken for Raynaud phenomenon.
Topics: Adult; Anesthetics, Local; Cyanosis; Diagnosis, Differential; Dyspnea; Female; Humans; Phenazopyridi | 2009 |
Phenazopyridine-induced sulfhemoglobinemia.
Topics: Administration, Oral; Female; Humans; Middle Aged; Phenazopyridine; Sulfhemoglobinemia; Urinary Trac | 2005 |
Phenazopyridine-induced sulfhemoglobinemia: inadvertent rechallenge.
Topics: Aged; Aged, 80 and over; Female; Humans; Methemoglobin; Phenazopyridine; Sulfhemoglobinemia | 1991 |
"Enterogenous" cyanosis.
Topics: Adult; Analgesics; Anesthetics, Local; Azo Compounds; Cyanosis; Female; Humans; Marfan Syndrome; Phe | 1970 |